(905558, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905559, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905560, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905561, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905562, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905563, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905564, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905565, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905566, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905567, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905568, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905569, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905570, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905571, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905572, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905573, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905574, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905575, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905576, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905577, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905578, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905579, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905580, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905581, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905582, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905583, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905584, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905585, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905586, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905587, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905588, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905589, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905590, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905591, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905592, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905593, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905594, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905595, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905596, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905597, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905598, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905599, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905600, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905601, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905602, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905603, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905604, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905605, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905606, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905607, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905608, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905609, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905610, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905611, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905612, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905613, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905614, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905615, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905616, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905617, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905618, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905619, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905620, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905621, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905622, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905623, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905624, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905625, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905626, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905627, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905628, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905629, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905630, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905631, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905632, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905633, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905634, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905635, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905636, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905637, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905638, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905639, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905640, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905641, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905642, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905643, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905644, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905645, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905646, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905647, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905648, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905649, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905650, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905651, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905652, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905653, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905654, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905655, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905656, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905657, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905658, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905659, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905660, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905661, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905662, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905663, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905664, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905665, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905666, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905667, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905668, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905669, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905670, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905671, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905672, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905673, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905674, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905675, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905676, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905677, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905678, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905679, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905680, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905681, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905682, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905683, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905684, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905685, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905686, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905687, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905688, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905689, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905690, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905691, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905692, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905693, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905694, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905695, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905696, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905697, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905698, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905699, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905700, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905701, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905702, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905703, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905704, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905705, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905706, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905707, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905708, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905709, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905710, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905711, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905712, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905713, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905714, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905715, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905716, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905717, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905718, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905719, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905720, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905721, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905722, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905723, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905724, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905725, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905726, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905727, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905728, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905729, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905730, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905731, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905732, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905733, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905734, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905735, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905736, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905737, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905738, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905739, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905740, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905741, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905742, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905743, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905744, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905745, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905746, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905747, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905748, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905749, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905750, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905751, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905752, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905753, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905754, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905755, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905756, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905757, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905758, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905759, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905760, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905761, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905762, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905763, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905764, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905765, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905766, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905767, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905768, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905769, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905770, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905771, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905772, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905773, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905774, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905775, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905776, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905777, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905778, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905779, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905780, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905781, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905782, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905783, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905784, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905785, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905786, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905787, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905788, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905789, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905790, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905791, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905792, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905793, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905794, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905795, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905796, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905797, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905798, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905799, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905800, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905801, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905802, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905803, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905804, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905805, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905806, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905807, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905808, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905809, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905810, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905811, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905812, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905813, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905814, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905815, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905816, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905817, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905818, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905819, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905820, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905821, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905822, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905823, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905824, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905825, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905826, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905827, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905828, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905829, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905830, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905831, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905832, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905833, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905834, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905835, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905836, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905837, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905838, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905839, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905840, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905841, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905842, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905843, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905844, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905845, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905846, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905847, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905848, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905849, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905850, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905851, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905852, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905853, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905854, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905855, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905856, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905857, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905858, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905859, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905860, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905861, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905862, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905863, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905864, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905865, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905866, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905867, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905868, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905869, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905870, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905871, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905872, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905873, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905874, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905875, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905876, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905877, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905878, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905879, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905880, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905881, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905882, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905883, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905884, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905885, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905886, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905887, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905888, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905889, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905890, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905891, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905892, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905893, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905894, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905895, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905896, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905897, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905898, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905899, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905900, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905901, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905902, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905903, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905904, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905905, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905906, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905907, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905908, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905909, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905910, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905911, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905912, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905913, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905914, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905915, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905916, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905917, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905918, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905919, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905920, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905921, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905922, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905923, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905924, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905925, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905926, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905927, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905928, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905929, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905930, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905931, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905932, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905933, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905934, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905935, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905936, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905937, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905938, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905939, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905940, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905941, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905942, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905943, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905944, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905945, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905946, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905947, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905948, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905949, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905950, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905951, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905952, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905953, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905954, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905955, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905956, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905957, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905958, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905959, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905960, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905961, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905962, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905963, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905964, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905965, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905966, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905967, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905968, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905969, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905970, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905971, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905972, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905973, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905974, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905975, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905976, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905977, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905978, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905979, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905980, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905981, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905982, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905983, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905984, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905985, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905986, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905987, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905988, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905989, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905990, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905991, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905992, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905993, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(905994, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905995, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905996, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905997, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905998, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(905999, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906000, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906001, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906002, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906003, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906004, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906005, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906006, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906007, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906008, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906009, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906010, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906011, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906012, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906013, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906014, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906015, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906016, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906017, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906018, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906019, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906020, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906021, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906022, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906023, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906024, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906025, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906026, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906027, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906028, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906029, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906030, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906031, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906032, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906033, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906034, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906035, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906036, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906037, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906038, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906039, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906040, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906041, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906042, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906043, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906044, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906045, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906046, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906047, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906048, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906049, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906050, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906051, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906052, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906053, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906054, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906055, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906056, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906057, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906058, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906059, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906060, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906061, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906062, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906063, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906064, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906065, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906066, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906067, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906068, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906069, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906070, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906071, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906072, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906073, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906074, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906075, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906076, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906077, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906078, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906079, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906080, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906081, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906082, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906083, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906084, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906085, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906086, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906087, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906088, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906089, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906090, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906091, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906092, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906093, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906094, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906095, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906096, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906097, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906098, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906099, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906100, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906101, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906102, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906103, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906104, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906105, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906106, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906107, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906108, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906109, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906110, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906111, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906112, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906113, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906114, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906115, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906116, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906117, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906118, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906119, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906120, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906121, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906122, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906123, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906124, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906125, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906126, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906127, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906128, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906129, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906130, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906131, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906132, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906133, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906134, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906135, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906136, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906137, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906138, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906139, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906140, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906141, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906142, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906143, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906144, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906145, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906146, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906147, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906148, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906149, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906150, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906151, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906152, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906153, 'HP:5000028', 'Anti-MAP1B antibody', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(906154, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014066', 'Rosenthal fibers', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906155, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003329', 'amyloid beta deposits', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906156, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000771', 'abnormal brain size', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906157, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008232', 'abnormal cingulum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906158, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.5185185185185185, 9.69625474174526, 2.242250575619931, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906159, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906160, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002924', 'delayed CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906161, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906162, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000914', 'exencephaly', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906163, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014063', 'Lafora bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906164, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0012712', 'spinal cord degeneration', 0.4375, 9.69625474174526, 2.059638669649012, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906165, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000847', 'abnormal metencephalon morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906166, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000913', 'abnormal brain development', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906167, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.5185185185185185, 9.69625474174526, 2.242250575619931, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906168, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000956', 'decreased spinal cord size', 0.42424242424242425, 9.69625474174526, 2.02819195780629, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906169, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0001891', 'hydrocephaly', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906170, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0021002', 'brain lesion', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906171, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.5185185185185185, 9.69625474174526, 2.242250575619931, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906172, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008026', 'abnormal brain white matter morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906173, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0001890', 'anencephaly', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906174, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009679', 'abnormal spinal cord ventral column morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906175, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0021142', 'abnormal brain N-acetyl-L-aspartic acid level', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906176, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0005277', 'abnormal brainstem morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906177, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000783', 'abnormal forebrain morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906178, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0012260', 'encephalomeningocele', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906179, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0001889', 'delayed brain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906180, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009637', 'abnormal pretectal region morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906181, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906182, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003864', 'abnormal midbrain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906183, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0012545', 'syringomyelia', 0.5384615384615384, 9.69625474174526, 2.2849639484147537, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906184, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.5185185185185185, 9.69625474174526, 2.242250575619931, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906185, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000778', 'abnormal nervous system tract morphology', 0.5, 5.838687225017717, 1.7086086774065203, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906186, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014278', 'semilobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906187, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0020452', 'abnormal axon radial sorting', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906188, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014277', 'alobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906189, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003634', 'abnormal glial cell morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906190, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000787', 'abnormal telencephalon morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906191, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0005112', 'abnormal spinal cord ventral horn morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906192, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002184', 'abnormal innervation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906193, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009694', 'abnormal spinal cord commissure morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906194, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014276', 'lobar holoprosencephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906195, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008025', 'brain vacuoles', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906196, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000897', 'abnormal midbrain morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906197, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004996', 'abnormal CNS synapse formation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906198, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009678', 'abnormal spinal cord lateral column morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906199, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000822', 'abnormal brain ventricle morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906200, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004203', 'abnormal cranial flexure morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906201, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906202, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906203, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0006282', 'abnormal spinal cord dorsal horn morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906204, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009677', 'abnormal spinal cord dorsal column morphology', 0.4666666666666667, 9.69625474174526, 2.127185671134779, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906205, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0006291', 'aprosencephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906206, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906207, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906208, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0005157', 'holoprosencephaly', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906209, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906210, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906211, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0001893', 'non-obstructive hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906212, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003861', 'abnormal nervous system development', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906213, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004166', 'abnormal limbic system morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906214, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002778', 'meroanencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906215, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906216, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014067', 'Hirano bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906217, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003632', 'abnormal nervous system morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906218, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0006108', 'abnormal hindbrain development', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906219, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0005623', 'abnormal meninges morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906220, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009684', 'abnormal spinal cord lateral motor column morphology', 0.42424242424242425, 9.69625474174526, 2.02819195780629, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906221, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0013934', 'supratentorial ventricles enlargement', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906222, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0006100', 'abnormal tegmentum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906223, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000841', 'abnormal hindbrain morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906224, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000917', 'obstructive hydrocephaly', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906225, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0020370', 'abnormal glymphatic system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906226, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003232', 'abnormal forebrain development', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906227, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906228, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014064', 'argyrophilic inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906229, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009024', 'abnormal brain arachnoid mater morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906230, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004997', 'increased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906231, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906232, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906233, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000955', 'abnormal spinal cord morphology', 0.56, 9.69625474174526, 2.3302151521645693, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906234, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000844', 'abnormal pontine flexure morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906235, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0013306', 'abnormal tela choroidea morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906236, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009032', 'abnormal subarachnoid cistern morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906237, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002199', 'abnormal brain commissure morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906238, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0030014', 'calcified brain', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906239, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008493', 'alpha-synuclein inclusion body', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906240, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0003214', 'neurofibrillary tangles', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906241, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009022', 'abnormal brain meninges morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906242, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014065', 'Lewy bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906243, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002653', 'abnormal ependyma morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906244, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002152', 'abnormal brain morphology', 0.5, 5.838687225017717, 1.7086086774065203, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906245, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906246, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0013935', 'basal brain tissue herniation', 0.48148148148148145, 5.838687225017717, 1.6766692503318983, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906247, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009695', 'abnormal spinal cord ventral commissure morphology', 0.45161290322580644, 9.69625474174526, 2.0925949809594235, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906248, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0012711', 'diplomyelia', 0.5384615384615384, 9.69625474174526, 2.2849639484147537, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906249, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009696', 'abnormal spinal cord grey commissure morphology', 0.42424242424242425, 9.69625474174526, 2.02819195780629, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906250, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004998', 'decreased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906251, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000849', 'abnormal cerebellum morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906252, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906253, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0006007', 'abnormal basal ganglion morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906254, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002809', 'increased spinal cord size', 0.42424242424242425, 9.69625474174526, 2.02819195780629, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906255, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009023', 'abnormal spinal cord meninges morphology', 0.4666666666666667, 9.69625474174526, 2.127185671134779, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906256, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009037', 'abnormal subarachnoid space development', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906257, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0000830', 'abnormal diencephalon morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906258, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014061', 'ethmocephaly', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906259, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0010744', 'abnormal cervical flexure morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906260, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009686', 'abnormal spinal cord medial motor column morphology', 0.4827586206896552, 9.69625474174526, 2.16355045353245, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906261, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0009682', 'abnormal anterior corticospinal tract morphology', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906262, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.4642857142857143, 5.838687225017717, 1.6464565189394542, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906263, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0004250', 'tau protein deposits', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906264, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0014062', 'nervous system inclusion bodies', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(906265, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0010151', 'abnormal spinal cord ependymal layer morphology', 0.45161290322580644, 9.69625474174526, 2.0925949809594235, 'UPHENO:0087858', 'abnormal spinal cord morphology'),
(906266, 'HP:0040272', 'Hyperintensity of MRI T2 signal of the spinal cord', 'MP:0008857', 'myelencephalic blebs', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(906267, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030615', 'ethylmalonic aciduria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906268, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0011765', 'oroticaciduria', 0.4927536231884058, 10.47786425096631, 2.272224806866592, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906269, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030632', 'increased urine creatine level', 0.41025641025641024, 11.094077685671904, 2.1334049044730112, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(906270, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030617', 'hyperglutaminuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906271, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0013730', 'glutathionuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906272, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020400', 'cystinuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906273, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0011516', 'aspartylglucosaminuria', 0.5797101449275363, 11.226325483970346, 2.5510810989296564, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906274, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030620', 'valinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906275, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0002931', 'glutaricadicuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906276, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0003311', 'aminoaciduria', 0.5882352941176471, 11.226325483970346, 2.5697705876057757, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906277, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0011470', 'increased urine creatinine level', 0.4444444444444444, 11.094077685671904, 2.22051822636788, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(906278, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030618', 'tryptophanuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906279, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020401', 'argininuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906280, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0011517', 'hyperoxaluria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906281, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0011654', 'histidinuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906282, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020403', 'lysinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906283, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030614', 'methylmalonic aciduria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906284, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030682', 'hydroxyprolinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906285, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030689', 'cystathioninuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906286, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020405', 'taurinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906287, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020404', 'prolinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906288, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030613', 'dicarboxylic aciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(906289, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020406', 'hyperthreoninuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906290, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0020402', 'ornithinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906291, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906292, 'HP:0034744', 'Elevated urinary S-sulfocysteine level', 'MP:0030616', 'hyperglycinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(906293, 'HP:0010891', 'Morbus Scheuermann', 'MP:0004610', 'small vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(906294, 'HP:0010891', 'Morbus Scheuermann', 'MP:0021136', 'abnormal vertebrae shape', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(906295, 'HP:0430008', 'Accessory eyelid', 'MP:0006164', 'ectropion', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(906296, 'HP:0430008', 'Accessory eyelid', 'MP:0006225', 'ocular rupture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(906297, 'HP:0430008', 'Accessory eyelid', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(906298, 'HP:0430008', 'Accessory eyelid', 'MP:0002697', 'abnormal eye size', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(906299, 'HP:0430008', 'Accessory eyelid', 'MP:0006166', 'eyelid retraction', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(906300, 'HP:0430008', 'Accessory eyelid', 'MP:0003671', 'abnormal eyelid aperture', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(906301, 'HP:0430008', 'Accessory eyelid', 'MP:0006209', 'calcified intraocular region', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(906302, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006138', 'congestive heart failure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906303, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906304, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906305, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906306, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011936', 'abnormal PP interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906307, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906308, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906309, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906310, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001914', 'hemorrhage', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906311, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004086', 'absent heartbeat', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906312, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003900', 'shortened QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906313, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906314, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906315, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906316, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012045', 'increased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906317, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031136', 'muscle hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906318, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906319, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006109', 'fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906320, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906321, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906322, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006114', 'cardiac murmur', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906323, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906324, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906325, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906326, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906327, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906328, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906329, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004120', 'cardiac ischemia', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906330, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906331, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003897', 'abnormal ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906332, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906333, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906334, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906335, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031302', 'syncope', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906336, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906337, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906338, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906339, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906340, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001596', 'hypotension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906341, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002626', 'increased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906342, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906343, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906344, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906345, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906346, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003038', 'decreased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906347, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013135', 'poor circulation in tail', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906348, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906349, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906350, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906351, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906352, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010519', 'atrioventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906353, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010553', 'prolonged HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906354, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031153', 'stomach hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906355, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005600', 'increased ventricle muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906356, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906357, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004085', 'abnormal heartbeat', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906358, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906359, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906360, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906361, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906362, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906363, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002128', 'abnormal blood circulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906364, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906365, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906366, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906367, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906368, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906369, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004878', 'increased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906370, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906371, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003233', 'prolonged QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906372, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906373, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004072', 'abnormal frontal plane axis', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906374, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906375, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906376, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906377, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031129', 'left-to-right shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906378, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906379, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906380, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906381, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906382, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906383, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906384, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003394', 'increased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906385, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906386, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906387, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906388, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906389, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010560', 'intraventricular block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906390, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906391, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906392, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906393, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004011', 'decreased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906394, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906395, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906396, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006044', 'tricuspid valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906397, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906398, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906399, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011926', 'abnormal heart valve physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906400, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906401, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906402, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906403, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013134', 'poor circulation in autopods', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906404, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031152', 'subcutaneous hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906405, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906406, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906407, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906408, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906409, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009698', 'heart hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906410, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001634', 'internal hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906411, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906412, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906413, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906414, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906415, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906416, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906417, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010571', 'shortened ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906418, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906419, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000465', 'gastrointestinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906420, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906421, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906422, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906423, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005330', 'cardiomyopathy', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906424, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003037', 'increased myocardial infarct size', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906425, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906426, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906427, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906428, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003548', 'pulmonary hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906429, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003896', 'prolonged PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906430, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906431, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906432, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010394', 'decreased QRS amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906433, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011953', 'prolonged PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906434, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906435, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906436, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011514', 'skin hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906437, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906438, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003393', 'decreased cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906439, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010554', 'shortened HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906440, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000233', 'abnormal blood flow velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906441, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004012', 'increased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906442, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906443, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906444, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906445, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906446, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906447, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906448, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906449, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010512', 'absent PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906450, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004245', 'genital hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906451, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906452, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906453, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906454, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906455, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906456, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011919', 'abnormal R wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906457, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010505', 'abnormal T wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906458, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006265', 'increased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906459, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906460, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006112', 'angina', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906461, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906462, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906463, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906464, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906465, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009275', 'bruising', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906466, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906467, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906468, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906469, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906470, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006048', 'pulmonary valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906471, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001629', 'abnormal heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906472, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906473, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004071', 'prolonged P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906474, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010507', 'shortened RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906475, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906476, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906477, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010514', 'fragmented QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906478, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001599', 'abnormal blood volume', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906479, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003928', 'increased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906480, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906481, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906482, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906483, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906484, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906485, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906486, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006045', 'mitral valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906487, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906488, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906489, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906490, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031192', 'coronary artery spasm', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906491, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906492, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906493, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906494, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906495, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906496, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001627', 'abnormal cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906497, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906498, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008950', 'ventricular tachycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906499, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020096', 'high mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906500, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906501, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906502, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906503, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906504, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906505, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906506, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906507, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906508, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906509, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906510, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011920', 'abnormal S wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906511, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906512, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003899', 'abnormal QT interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906513, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906514, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906515, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906516, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906517, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906518, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009384', 'cardiac valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906519, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906520, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906521, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011937', 'shortened PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906522, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906523, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906524, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906525, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906526, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011951', 'increased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906527, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906528, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011929', 'abnormal aortic valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906529, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013127', 'epistaxis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906530, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010510', 'absent P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906531, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031128', 'cardiovascular shunt', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906532, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906533, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906534, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906535, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906536, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906537, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005532', 'abnormal vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906538, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906539, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906540, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906541, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906542, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906543, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906544, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906545, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906546, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906547, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906548, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003901', 'abnormal PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906549, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906550, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011938', 'prolonged PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906551, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906552, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906553, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906554, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906555, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031130', 'right-to-left shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906556, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906557, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906558, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906559, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010636', 'bundle branch block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906560, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906561, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906562, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010511', 'shortened PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906563, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010506', 'prolonged RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906564, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005333', 'decreased heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906565, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906566, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010559', 'heart block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906567, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906568, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906569, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001636', 'irregular heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906570, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031154', 'intestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906571, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906572, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906573, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906574, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906575, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906576, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906577, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906578, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906579, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906580, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906581, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906582, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010504', 'abnormal RR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906583, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000249', 'abnormal blood vessel physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906584, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906585, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906586, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906587, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003929', 'decreased heart rate variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906588, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906589, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906590, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906591, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906592, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003882', 'abnormal pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906593, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906594, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906595, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011927', 'abnormal cardiac valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906596, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906597, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906598, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906599, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906600, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906601, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906602, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906603, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906604, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906605, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906606, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906607, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906608, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906609, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906610, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003823', 'increased left ventricle developed pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906611, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906612, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906613, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906614, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906615, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906616, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906617, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906618, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004879', 'decreased systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906619, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906620, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906621, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004217', 'salt-sensitive hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906622, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906623, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906624, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010637', 'sinus bradycardia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906625, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906626, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906627, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006266', 'decreased pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906628, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010513', 'abnormal ventricular activation time', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906629, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906630, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906631, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906632, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906633, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906634, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008776', 'increased right ventricle peak pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906635, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010552', 'abnormal HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906636, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020097', 'low mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906637, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906638, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906639, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906640, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031170', 'abnormal vasculature physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906641, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906642, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906643, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906644, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906645, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906646, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906647, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906648, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906649, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906650, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010631', 'increased Q wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906651, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906652, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000231', 'hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906653, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906654, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004156', 'abnormal QT variability', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906655, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906656, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906657, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906658, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906659, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004216', 'salt-resistant hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906660, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906661, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906662, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906663, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906664, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906665, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011918', 'abnormal PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906666, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906667, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906668, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906669, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906670, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906671, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906672, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002952', 'ventricular cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906673, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906674, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906675, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906676, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003547', 'abnormal pulmonary pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906677, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906678, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906679, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004010', 'increased diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906680, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906681, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906682, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010634', 'increased QRS amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906683, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906684, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906685, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906686, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906687, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906688, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001598', 'abnormal blood viscosity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906689, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001633', 'poor circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906690, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011952', 'decreased cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906691, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010570', 'prolonged ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906692, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906693, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906694, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011928', 'abnormal mitral valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906695, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003438', 'abnormal carotid body physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906696, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906697, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906698, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906699, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906700, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005435', 'hemoperitoneum', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906701, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004485', 'increased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906702, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906703, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906704, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906705, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906706, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906707, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006049', 'semilunar valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906708, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906709, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906710, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906711, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906712, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906713, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005599', 'increased cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906714, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906715, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010516', 'absent Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906716, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906717, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906718, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906719, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011954', 'shortened PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906720, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906721, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906722, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906723, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003549', 'pulmonary hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906724, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906725, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010393', 'shortened QRS complex duration', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906726, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906727, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010515', 'abnormal Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906728, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906729, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906730, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906731, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010509', 'decreased P wave amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906732, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006111', 'abnormal coronary circulation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906733, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906734, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906735, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906736, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906737, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906738, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0020418', 'increased cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906739, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906740, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906741, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0009732', 'ventricular premature beat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906742, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906743, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906744, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906745, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906746, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906747, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004486', 'decreased response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906748, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906749, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0003898', 'abnormal QRS complex', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906750, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906751, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010695', 'abnormal blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906752, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004070', 'abnormal P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906753, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010520', 'sinoatrial block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906754, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906755, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906756, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906757, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0008817', 'hematoma', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906758, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0010392', 'prolonged QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906759, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0006047', 'aortic valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906760, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004013', 'decreased pulmonary artery pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906761, 'HP:0033756', 'Decreased left ventricular end-diastolic volume', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906762, 'HP:3000020', 'Abnormality of zygomaticus minor muscle', 'MP:0030184', 'abnormal zygomaticus muscle morphology', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0087116', 'abnormal cheek morphology'),
(906763, 'HP:3000020', 'Abnormality of zygomaticus minor muscle', 'MP:0030151', 'abnormal buccinator muscle morphology', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0087116', 'abnormal cheek morphology'),
(906764, 'HP:3000020', 'Abnormality of zygomaticus minor muscle', 'MP:0030185', 'abnormal minor zygomaticus muscle morphology', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0087116', 'abnormal cheek morphology'),
(906765, 'HP:3000020', 'Abnormality of zygomaticus minor muscle', 'MP:0030186', 'abnormal major zygomaticus muscle morphology', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0087116', 'abnormal cheek morphology'),
(906766, 'HP:3000020', 'Abnormality of zygomaticus minor muscle', 'MP:0030246', 'abnormal cheek morphology', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0087116', 'abnormal cheek morphology'),
(906767, 'HP:0004035', 'Abnormal ulnar styloid process morphology', 'MP:0030903', 'small ulnar styloid process', 0.4268292682926829, 15.022184767190119, 2.53217458567478, 'UPHENO:0088054', 'abnormal styloid process of ulna morphology'),
(906768, 'HP:0004035', 'Abnormal ulnar styloid process morphology', 'MP:0030901', 'increased ulna size', 0.4230769230769231, 12.237913458245556, 2.2754293596585673, 'UPHENO:0020868', 'abnormal ulna morphology'),
(906769, 'HP:0004035', 'Abnormal ulnar styloid process morphology', 'MP:0008163', 'increased diameter of ulna', 0.4125, 12.237913458245556, 2.2468064673056047, 'UPHENO:0020868', 'abnormal ulna morphology'),
(906770, 'HP:0004035', 'Abnormal ulnar styloid process morphology', 'MP:0030900', 'decreased ulna size', 0.4177215189873418, 12.237913458245556, 2.2609820430542933, 'UPHENO:0020868', 'abnormal ulna morphology'),
(906771, 'HP:0004035', 'Abnormal ulnar styloid process morphology', 'MP:0008157', 'decreased diameter of ulna', 0.4074074074074074, 12.237913458245556, 2.2328942191917736, 'UPHENO:0020868', 'abnormal ulna morphology'),
(906772, 'HP:0000276', 'Long face', 'MP:0002758', 'long tail', 0.4222222222222222, 10.073168695908924, 2.0623083357262537, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906773, 'HP:0000276', 'Long face', 'MP:0020302', 'large horns', 0.43478260869565216, 5.9605885577567275, 1.6098323647209123, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906774, 'HP:0000276', 'Long face', 'MP:0030063', 'abnormal face size', 0.5, 13.607147267911277, 2.6083660851106845, 'UPHENO:0075171', 'abnormal size of face'),
(906775, 'HP:0000276', 'Long face', 'MP:0030067', 'narrow face', 0.4230769230769231, 13.607147267911277, 2.3993478276320137, 'UPHENO:0075171', 'abnormal size of face'),
(906776, 'HP:0000276', 'Long face', 'MP:0030189', 'broad snout', 0.43137254901960786, 5.9605885577567275, 1.603506869276408, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906777, 'HP:0000276', 'Long face', 'MP:0006162', 'thick eyelids', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906778, 'HP:0000276', 'Long face', 'MP:0030041', 'abnormal forehead size', 0.4166666666666667, 5.913369942082322, 1.5696828159008114, 'UPHENO:0087472', 'abnormal face morphology'),
(906779, 'HP:0000276', 'Long face', 'MP:0003765', 'increased palatal length', 0.4166666666666667, 10.073168695908924, 2.048695590685787, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906780, 'HP:0000276', 'Long face', 'MP:0001305', 'enlarged lens', 0.4074074074074074, 5.9605885577567275, 1.5583285696341211, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906781, 'HP:0000276', 'Long face', 'MP:0000434', 'megacephaly', 0.43478260869565216, 5.9605885577567275, 1.6098323647209123, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906782, 'HP:0000276', 'Long face', 'MP:0009274', 'buphthalmos', 0.41509433962264153, 5.9605885577567275, 1.5729610837984207, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906783, 'HP:0000276', 'Long face', 'MP:0030066', 'short face', 0.4423076923076923, 13.607147267911277, 2.453272489341687, 'UPHENO:0075171', 'abnormal size of face'),
(906784, 'HP:0000276', 'Long face', 'MP:0000548', 'long limbs', 0.4222222222222222, 10.073168695908924, 2.0623083357262537, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906785, 'HP:0000276', 'Long face', 'MP:0012720', 'elongated neck', 0.45652173913043476, 10.073168695908924, 2.1444394352861997, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906786, 'HP:0000276', 'Long face', 'MP:0030166', 'increased inner canthal distance', 0.4716981132075472, 10.073168695908924, 2.179792345128675, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906787, 'HP:0000276', 'Long face', 'MP:0030042', 'large forehead', 0.44, 5.9605885577567275, 1.6194625544954597, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906788, 'HP:0000276', 'Long face', 'MP:0020085', 'long ears', 0.4339622641509434, 10.073168695908924, 2.0907833686087716, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906789, 'HP:0000276', 'Long face', 'MP:0001296', 'macrophthalmia', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906790, 'HP:0000276', 'Long face', 'MP:0030070', 'long face', 0.6304347826086957, 16.607147267911277, 3.235695176866362, 'UPHENO:0072219', 'increased length of the face'),
(906791, 'HP:0000276', 'Long face', 'MP:0001300', 'ocular hypertelorism', 0.4716981132075472, 10.073168695908924, 2.179792345128675, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906792, 'HP:0000276', 'Long face', 'MP:0030065', 'face hypoplasia', 0.41509433962264153, 13.607147267911277, 2.3766046809096504, 'UPHENO:0075171', 'abnormal size of face'),
(906793, 'HP:0000276', 'Long face', 'MP:0000446', 'long snout', 0.5102040816326531, 10.073168695908924, 2.2670182583356056, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906794, 'HP:0000276', 'Long face', 'MP:0030069', 'broad face', 0.5102040816326531, 15.022184767190119, 2.7684616636789943, 'UPHENO:0001260', 'increased size of the face'),
(906795, 'HP:0000276', 'Long face', 'MP:0001281', 'increased vibrissae length', 0.40425531914893614, 10.073168695908924, 2.0179524340295374, 'UPHENO:0055730', 'increased anatomical entity length in independent continuant'),
(906796, 'HP:0000276', 'Long face', 'MP:0013396', 'eyelid hyperplasia', 0.4230769230769231, 5.9605885577567275, 1.5880136859433016, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(906797, 'HP:0000276', 'Long face', 'MP:0030068', 'large face', 0.5555555555555556, 15.022184767190119, 2.8888852874412496, 'UPHENO:0001260', 'increased size of the face'),
(906798, 'HP:0000276', 'Long face', 'MP:0030064', 'small face', 0.4583333333333333, 13.607147267911277, 2.497320396837245, 'UPHENO:0075171', 'abnormal size of face'),
(906799, 'HP:0000276', 'Long face', 'MP:0011496', 'abnormal head size', 0.4090909090909091, 4.6730878730104815, 1.382648822453323, 'UPHENO:0087907', 'abnormal head morphology'),
(906800, 'HP:0000276', 'Long face', 'MP:0030071', 'abnormal face shape', 0.40816326530612246, 11.592196926445306, 2.1752031973058314, 'UPHENO:0020809', 'abnormal face morphology'),
(906801, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906802, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906803, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005599', 'increased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906804, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010631', 'increased Q wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906805, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004085', 'abnormal heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906806, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906807, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003548', 'pulmonary hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906808, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000233', 'abnormal blood flow velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906809, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011929', 'abnormal aortic valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906810, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906811, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906812, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005330', 'cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906813, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031192', 'coronary artery spasm', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906814, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011954', 'shortened PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906815, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010392', 'prolonged QRS complex duration', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906816, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906817, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906818, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906819, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906820, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906821, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906822, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906823, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020097', 'low mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906824, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003038', 'decreased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906825, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906826, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906827, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004485', 'increased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906828, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906829, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906830, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906831, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005333', 'decreased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906832, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906833, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906834, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010570', 'prolonged ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906835, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906836, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906837, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906838, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906839, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006047', 'aortic valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906840, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906841, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010560', 'intraventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906842, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906843, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003547', 'abnormal pulmonary pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906844, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906845, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906846, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906847, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031152', 'subcutaneous hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906848, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906849, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906850, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906851, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906852, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906853, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003899', 'abnormal QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906854, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004878', 'increased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906855, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011926', 'abnormal heart valve physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906856, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010519', 'atrioventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906857, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906858, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010394', 'decreased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906859, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031136', 'muscle hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906860, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906861, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006266', 'decreased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906862, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906863, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906864, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906865, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011953', 'prolonged PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906866, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906867, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906868, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003928', 'increased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906869, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006138', 'congestive heart failure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906870, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906871, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906872, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906873, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002626', 'increased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906874, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906875, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906876, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906877, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003901', 'abnormal PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906878, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906879, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906880, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013134', 'poor circulation in autopods', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906881, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011952', 'decreased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906882, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002952', 'ventricular cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906883, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906884, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906885, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906886, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004011', 'decreased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906887, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006049', 'semilunar valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906888, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004879', 'decreased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906889, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906890, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003394', 'increased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906891, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010512', 'absent PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906892, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010507', 'shortened RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906893, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906894, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906895, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906896, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001599', 'abnormal blood volume', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906897, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906898, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906899, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906900, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031302', 'syncope', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906901, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906902, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003034', 'increased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906903, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010553', 'prolonged HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906904, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906905, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004216', 'salt-resistant hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906906, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906907, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001634', 'internal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906908, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906909, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906910, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010571', 'shortened ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906911, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906912, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001629', 'abnormal heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906913, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906914, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000231', 'hypertension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906915, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906916, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001636', 'irregular heartbeat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906917, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906918, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906919, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001633', 'poor circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906920, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013127', 'epistaxis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906921, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906922, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906923, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010506', 'prolonged RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906924, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001914', 'hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906925, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906926, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906927, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906928, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906929, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003897', 'abnormal ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906930, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031128', 'cardiovascular shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906931, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010637', 'sinus bradycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906932, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906933, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020096', 'high mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906934, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004012', 'increased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906935, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906936, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003549', 'pulmonary hypotension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906937, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906938, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010393', 'shortened QRS complex duration', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906939, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906940, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010511', 'shortened PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906941, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906942, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906943, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011927', 'abnormal cardiac valve flow', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906944, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011920', 'abnormal S wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906945, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004486', 'decreased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906946, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906947, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003037', 'increased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906948, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010509', 'decreased P wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906949, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906950, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906951, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906952, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011928', 'abnormal mitral valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906953, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004072', 'abnormal frontal plane axis', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906954, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906955, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906956, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010634', 'increased QRS amplitude', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906957, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906958, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011938', 'prolonged PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906959, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010559', 'heart block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906960, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906961, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906962, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906963, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906964, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031130', 'right-to-left shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906965, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004245', 'genital hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906966, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009698', 'heart hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906967, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906968, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906969, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010504', 'abnormal RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906970, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906971, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906972, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011514', 'skin hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906973, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906974, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008817', 'hematoma', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906975, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010636', 'bundle branch block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906976, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906977, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010514', 'fragmented QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906978, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003898', 'abnormal QRS complex', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906979, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003393', 'decreased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906980, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906981, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906982, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906983, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906984, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006111', 'abnormal coronary circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906985, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906986, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011951', 'increased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906987, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906988, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906989, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906990, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010520', 'sinoatrial block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906991, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906992, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906993, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906994, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906995, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906996, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(906997, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012046', 'decreased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906998, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(906999, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907000, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907001, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001598', 'abnormal blood viscosity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907002, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010510', 'absent P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907003, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907004, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006265', 'increased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907005, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907006, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907007, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907008, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907009, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907010, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004086', 'absent heartbeat', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907011, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907012, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001596', 'hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907013, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907014, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907015, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907016, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907017, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011936', 'abnormal PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907018, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002128', 'abnormal blood circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907019, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907020, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907021, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907022, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907023, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907024, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907025, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031170', 'abnormal vasculature physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907026, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907027, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907028, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010695', 'abnormal blood pressure regulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907029, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907030, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907031, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907032, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005532', 'abnormal vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907033, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005435', 'hemoperitoneum', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907034, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006114', 'cardiac murmur', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907035, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013135', 'poor circulation in tail', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907036, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907037, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907038, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006048', 'pulmonary valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907039, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003896', 'prolonged PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907040, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010515', 'abnormal Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907041, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907042, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907043, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008776', 'increased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907044, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004010', 'increased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907045, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907046, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907047, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008950', 'ventricular tachycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907048, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011918', 'abnormal PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907049, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907050, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003233', 'prolonged QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907051, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907052, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907053, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009275', 'bruising', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907054, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907055, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009732', 'ventricular premature beat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907056, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907057, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907058, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907059, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0000249', 'abnormal blood vessel physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907060, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012045', 'increased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907061, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907062, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907063, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010505', 'abnormal T wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907064, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907065, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907066, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907067, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907068, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004156', 'abnormal QT variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907069, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907070, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011919', 'abnormal R wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907071, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907072, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907073, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907074, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907075, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907076, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010552', 'abnormal HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907077, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003900', 'shortened QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907078, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907079, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001627', 'abnormal cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907080, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907081, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907082, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907083, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003438', 'abnormal carotid body physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907084, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907085, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907086, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010516', 'absent Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907087, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006044', 'tricuspid valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907088, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907089, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907090, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907091, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907092, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907093, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010513', 'abnormal ventricular activation time', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907094, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004071', 'prolonged P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907095, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003882', 'abnormal pulse pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907096, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907097, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907098, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907099, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907100, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907101, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031129', 'left-to-right shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907102, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009384', 'cardiac valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907103, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907104, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907105, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907106, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907107, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907108, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907109, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0010554', 'shortened HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907110, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004217', 'salt-sensitive hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907111, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907112, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907113, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003929', 'decreased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907114, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011937', 'shortened PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907115, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907116, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004070', 'abnormal P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907117, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907118, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0006045', 'mitral valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907119, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907120, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0003823', 'increased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907121, 'HP:0025073', 'Exercise-induced U wave inversion', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(907122, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907123, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907124, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005311', 'abnormal circulating amino acid level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907125, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012620', 'abnormal circulating factor XIII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907126, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907127, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008548', 'abnormal circulating interferon level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907128, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012333', 'increased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907129, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010089', 'abnormal circulating creatine kinase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907130, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031065', 'increased circulating procalcitonin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907131, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012614', 'abnormal circulating factor IX level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907132, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0001570', 'abnormal circulating enzyme level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907133, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907134, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011611', 'abnormal circulating ghrelin level', 0.4318181818181818, 8.001050554100775, 1.8587627882296205, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907135, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907136, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020985', 'increased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907137, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907138, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907139, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0004730', 'abnormal circulating gastrin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907140, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012326', 'increased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907141, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012621', 'decreased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907142, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012332', 'decreased circulating fibronectin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907143, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021037', 'abnormal circulating orosomucoid 1 protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907144, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021039', 'decreased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907145, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031075', 'abnormal circulating troponin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907146, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012666', 'increased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907147, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012615', 'decreased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907148, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031077', 'increased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907149, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907150, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021038', 'increased circulating orosomucoid 1 protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907151, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031079', 'increased circulating troponin I level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907152, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010090', 'increased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907153, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907154, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012616', 'increased circulating factor IX level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907155, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0013255', 'abnormal circulating thrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907156, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012221', 'abnormal circulating prothrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907157, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010214', 'abnormal circulating serum amyloid protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907158, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0003349', 'abnormal circulating renin level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907159, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010209', 'abnormal circulating chemokine level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907160, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907161, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012664', 'decreased circulating haptoglobin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907162, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907163, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031081', 'abnormal circulating D-dimer level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907164, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011971', 'increased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907165, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010213', 'abnormal circulating fibrinogen level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907166, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0013256', 'increased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907167, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031234', 'increased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907168, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0013403', 'abnormal circulating lactate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(907169, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012618', 'decreased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907170, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011885', 'abnormal circulating lipase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907171, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012222', 'decreased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907172, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010091', 'decreased circulating creatine kinase level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907173, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031107', 'abnormal circulating myoglobin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907174, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012223', 'increased circulating prothrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907175, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011889', 'abnormal circulating ferritin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907176, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012328', 'decreased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907177, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020257', 'increased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907178, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031243', 'abnormal circulating CSF3 level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907179, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031078', 'increased circulating troponin T level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907180, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011892', 'abnormal circulating transferrin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907181, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020216', 'decreased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907182, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031108', 'increased circulating myoglobin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907183, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907184, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011894', 'decreased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907185, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907186, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907187, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0002941', 'increased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907188, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012662', 'increased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907189, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010210', 'abnormal circulating cytokine level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907190, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010333', 'abnormal circulating apolipoprotein E level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907191, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907192, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011972', 'decreased circulating lactate dehydrogenase level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907193, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0002965', 'increased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907194, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0030757', 'abnormal circulating histamine level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907195, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012331', 'increased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907196, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020246', 'abnormal circulating arginase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907197, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012330', 'decreased circulating fibrinogen level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907198, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012622', 'increased circulating factor XIII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907199, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011896', 'increased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907200, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907201, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012324', 'abnormal circulating antithrombin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907202, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012661', 'decreased circulating ceruloplasmin level', 0.4772727272727273, 9.555485148088783, 2.135549684985665, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907203, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012327', 'abnormal circulating factor VIII level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907204, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020217', 'increased circulating complement protein level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907205, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907206, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031076', 'decreased circulating troponin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907207, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012617', 'abnormal circulating factor X level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907208, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907209, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0001560', 'abnormal circulating insulin level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907210, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031341', 'decreased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907211, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010215', 'abnormal circulating complement protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907212, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012329', 'increased circulating factor VIII level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907213, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005416', 'abnormal circulating protein level', 0.5384615384615384, 9.555485148088783, 2.268316828308221, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907214, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907215, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0002695', 'abnormal circulating glucagon level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907216, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0013257', 'decreased circulating thrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907217, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907218, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0009699', 'hyperchylomicronemia', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907219, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008588', 'abnormal circulating interleukin level', 0.40384615384615385, 9.555485148088783, 1.9644199971466643, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907220, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0030624', 'abnormal circulating cysteine level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907221, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020984', 'decreased circulating factor XI level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907222, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020256', 'abnormal circulating factor XII level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907223, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020255', 'absent circulating factor XII protein', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907224, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020248', 'decreased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907225, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011897', 'decreased circulating unsaturated transferrin level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907226, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907227, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.45652173913043476, 9.555485148088783, 2.088608794877713, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907228, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031060', 'decreased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907229, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907230, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010212', 'abnormal circulating C-reactive protein level', 0.42, 9.555485148088783, 2.003323179668545, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907231, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0030744', 'abnormal circulating homocitrulline level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907232, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011890', 'increased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907233, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008820', 'abnormal blood uric acid level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907234, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031342', 'increased circulating lipocalin 2 level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907235, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907236, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005667', 'abnormal circulating leptin level', 0.4222222222222222, 8.001050554100775, 1.8379938370584303, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907237, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011891', 'decreased circulating ferritin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907238, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031059', 'increased circulating C-reactive protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907239, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011886', 'increased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907240, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011887', 'decreased circulating lipase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907241, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020983', 'abnormal circulating factor XI level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907242, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0000188', 'abnormal circulating glucose level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(907243, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005419', 'decreased circulating serum albumin level', 0.4666666666666667, 9.555485148088783, 2.111688045721108, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907244, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907245, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031082', 'decreased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907246, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907247, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011970', 'abnormal circulating lactate dehydrogenase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907248, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0030745', 'increased circulating homocitrulline level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907249, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020258', 'decreased circulating factor XII level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907250, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907251, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008804', 'abnormal circulating amylase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907252, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011912', 'abnormal circulating fibronectin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907253, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031083', 'increased circulating D-dimer level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907254, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008806', 'increased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907255, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0020247', 'increased circulating arginase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907256, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907257, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031233', 'decreased circulating serum amyloid protein level', 0.4117647058823529, 9.555485148088783, 1.9835855241370284, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907258, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.44680851063829785, 9.555485148088783, 2.0662700906328593, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907259, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.5, 9.555485148088783, 2.185804788640649, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907260, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907261, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005308', 'abnormal circulating ammonia level', 0.4418604651162791, 8.001050554100775, 1.880252089283198, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907262, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.40425531914893614, 8.001050554100775, 1.7984624670186424, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907263, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012619', 'increased circulating factor X level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907264, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907265, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0012325', 'decreased circulating antithrombin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907266, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011888', 'abnormal circulating total protein level', 0.525, 9.555485148088783, 2.2397834053199457, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907267, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0008805', 'decreased circulating amylase level', 0.4883720930232558, 9.555485148088783, 2.160238940863893, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907268, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005567', 'decreased circulating total protein level', 0.4375, 9.555485148088783, 2.0446331583657846, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907269, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.475, 8.001050554100775, 1.9494868589446475, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(907270, 'HP:0033123', 'Elevated circulating osteopontin level', 'MP:0011893', 'increased circulating transferrin level', 0.5121951219512195, 9.555485148088783, 2.212300359519114, 'UPHENO:0051612', 'abnormal blood protein polypeptide chain level'),
(907271, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004835', 'abnormal miniature endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907272, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907273, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003633', 'abnormal nervous system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907274, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008840', 'abnormal spike wave discharge', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907275, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003463', 'abnormal single cell response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907276, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907277, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006060', 'increased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907278, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907279, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907280, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001500', 'decreased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907281, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907282, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907283, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009141', 'increased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907284, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907285, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907286, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009142', 'decreased prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907287, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907288, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012011', 'febrile seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907289, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907290, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907291, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907292, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907293, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002914', 'abnormal endplate potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907294, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907295, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003997', 'tonic-clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907296, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907297, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907298, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002207', 'abnormal long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907299, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907300, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907301, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907302, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907303, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013438', 'dysmyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907304, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907305, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907306, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021001', 'impaired neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907307, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002920', 'decreased paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907308, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003880', 'abnormal central pattern generator function', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907309, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003466', 'decreased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907310, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003489', 'increased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907311, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907312, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907313, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907314, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003487', 'increased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907315, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907316, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907317, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907318, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907319, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907320, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907321, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907322, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009358', 'environmentally induced seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907323, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907324, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907325, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004513', 'avnosmia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907326, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907327, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003488', 'decreased channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907328, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907329, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003473', 'decreased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907330, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907331, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907332, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907333, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907334, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907335, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907336, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907337, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907338, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907339, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907340, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907341, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907342, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907343, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907344, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907345, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907346, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002915', 'abnormal synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907347, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006058', 'decreased cerebral infarct size', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907348, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003996', 'clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907349, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003480', 'increased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907350, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907351, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003464', 'abnormal single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907352, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907353, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907354, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907355, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907356, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907357, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907358, 'HP:0033689', 'Anterograde memory impairment', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907359, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907360, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003217', 'increased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907361, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003482', 'increased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907362, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011994', 'increased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907363, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005402', 'abnormal action potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907364, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907365, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004811', 'abnormal neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907366, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002064', 'seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907367, 'HP:0033689', 'Anterograde memory impairment', 'MP:0014254', 'increased paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907368, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907369, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907370, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907371, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020424', 'increased kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907372, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907373, 'HP:0033689', 'Anterograde memory impairment', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907374, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907375, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907376, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907377, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907378, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907379, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907380, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003475', 'increased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907381, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907382, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907383, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003008', 'enhanced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907384, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001915', 'intracranial hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907385, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002635', 'reduced sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907386, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907387, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013806', 'encephalopathy', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907388, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000920', 'abnormal myelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907389, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907390, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000947', 'convulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907391, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907392, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001898', 'abnormal long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907393, 'HP:0033689', 'Anterograde memory impairment', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907394, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907395, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907396, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000948', 'nonconvulsive seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907397, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907398, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907399, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907400, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907401, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012006', 'abnormal hippocampus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907402, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907403, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907404, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907405, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002578', 'impaired ability to fire action potentials', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907406, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010050', 'hypermyelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907407, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021010', 'impaired synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907408, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907409, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907410, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907411, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907412, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907413, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003471', 'abnormal summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907414, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907415, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907416, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907417, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003474', 'abnormal summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907418, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907419, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003218', 'decreased spike-wave discharge type I', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907420, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907421, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907422, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003219', 'increased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907423, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907424, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907425, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907426, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907427, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907428, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907429, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004768', 'abnormal axonal transport', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907430, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907431, 'HP:0033689', 'Anterograde memory impairment', 'MP:0014120', 'focal seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907432, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907433, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907434, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907435, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002195', 'psychomotor seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907436, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003216', 'absence seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907437, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907438, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003476', 'decreased summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907439, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003485', 'abnormal channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907440, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003469', 'decreased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907441, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907442, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907443, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907444, 'HP:0033689', 'Anterograde memory impairment', 'MP:0014255', 'increased paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907445, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003477', 'abnormal nerve fiber response', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907446, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907447, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003467', 'abnormal single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907448, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907449, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907450, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907451, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907452, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907453, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907454, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907455, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907456, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003220', 'decreased spike-wave discharge type II', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907457, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907458, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001473', 'reduced long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907459, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907460, 'HP:0033689', 'Anterograde memory impairment', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907461, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907462, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907463, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907464, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907465, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907466, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907467, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003990', 'decreased neurotransmitter release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907468, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907469, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003635', 'abnormal synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907470, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002634', 'abnormal sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907471, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002923', 'increased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907472, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907473, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000951', 'sporadic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907474, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003486', 'abnormal channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907475, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907476, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002917', 'decreased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907477, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907478, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907479, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002826', 'tonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907480, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907481, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907482, 'HP:0033689', 'Anterograde memory impairment', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907483, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907484, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907485, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907486, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907487, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907488, 'HP:0033689', 'Anterograde memory impairment', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907489, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907490, 'HP:0033689', 'Anterograde memory impairment', 'MP:0009967', 'abnormal neuron proliferation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907491, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907492, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003490', 'decreased channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907493, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003468', 'increased single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907494, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907495, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907496, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907497, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907498, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005403', 'abnormal nerve conduction', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907499, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907500, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907501, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021009', 'abnormal synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907502, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907503, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907504, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006080', 'brain ischemia', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907505, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004859', 'abnormal synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907506, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907507, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907508, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907509, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907510, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907511, 'HP:0033689', 'Anterograde memory impairment', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907512, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907513, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001900', 'impaired synaptic plasticity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907514, 'HP:0033689', 'Anterograde memory impairment', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907515, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907516, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001496', 'audiogenic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907517, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003470', 'abnormal summary potential', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907518, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907519, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907520, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907521, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002916', 'increased synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907522, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907523, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907524, 'HP:0033689', 'Anterograde memory impairment', 'MP:0021015', 'increased tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907525, 'HP:0033689', 'Anterograde memory impairment', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907526, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907527, 'HP:0033689', 'Anterograde memory impairment', 'MP:0002193', 'minimal clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907528, 'HP:0033689', 'Anterograde memory impairment', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(907529, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907530, 'HP:0033689', 'Anterograde memory impairment', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907531, 'HP:0033689', 'Anterograde memory impairment', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907532, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003472', 'increased summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907533, 'HP:0033689', 'Anterograde memory impairment', 'MP:0008814', 'decreased nerve conduction velocity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907534, 'HP:0033689', 'Anterograde memory impairment', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907535, 'HP:0033689', 'Anterograde memory impairment', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907536, 'HP:0033689', 'Anterograde memory impairment', 'MP:0003465', 'increased single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907537, 'HP:0033689', 'Anterograde memory impairment', 'MP:0001499', 'abnormal kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907538, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004494', 'abnormal synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(907539, 'HP:0033689', 'Anterograde memory impairment', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
